Literature DB >> 331108

Autoimmune vitiligo: detection of antibodies to melanin-producing cells.

K C Hertz, L A Gazze, C H Kirkpatrick, S I Katz.   

Abstract

Vitiligo, a disorder characterized by the destruction of melanocytes, is often associated with diseases in which there are increased frequencies of autoantibodies. For this reason we investigated two patients with vitiligo, alopecia universalis, mucocutaneous candidiasis, and multiple endocrine insufficiencies for antibodies to melanin-producing cells. Using direct immunofluorescence of normal and vitiliginous skin from both patients and indirect immunofluorescence with both patients' serum, we could not detect these antibodies. However, an immunofluorescent complement-fixation test demonstrated a circulating antibody that bound to melanocytes in human skin, nevus cells and melanoma cells. Specificity of cellular fluorescence for nevus and melanoma cells was shown on serial sections stained with hematoxylin and eosin and was inferred for melanocytes from their distribution in human skin and their presence when the normal but not vitiliginous skin of both patients was used as substrate. This antibody was characterized as an IgG that activated complement via the classical pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331108     DOI: 10.1056/NEJM197709222971204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  23 in total

Review 1.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Authors:  P Agretti; G De Marco; D Sansone; C Betterle; G Coco; A Dimida; E Ferrarini; A Pinchera; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

3.  T and B lymphocytes in vitiligo.

Authors:  J P Ortonne; A Alario
Journal:  Arch Dermatol Res       Date:  1978-04-07       Impact factor: 3.017

4.  Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.

Authors:  D R Vlock; J M Kirkwood
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

5.  Alopecia areata.

Authors: 
Journal:  Br Med J       Date:  1979-02-24

Review 6.  Immunologically mediated epidermal cell injury.

Authors:  R D Sontheimer; J N Gilliam
Journal:  Springer Semin Immunopathol       Date:  1981-06

7.  Natural history of cutaneous malignant melanoma.

Authors:  H A Briele; T K Das Gupta
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

8.  Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma.

Authors:  M A Chang; G Fournier; H K Koh; A J Sober; H Nakagawa; T B Fitzpatrick; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

9.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.

Authors:  O Merimsky; Y Shoenfeld; G Yecheskel; S Chaitchik; E Azizi; P Fishman
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

Review 10.  The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.

Authors:  O Merimsky; Y Shoenfeld; P Fishman
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.